# Paper test review — 19 October 2026

No new reproduced failure or justified strategy change. Preserve running experiments and paper-only controls.

## Exact tested sources

| Scope | Source revision | Deployment fixtures | Research fixtures |
| --- | --- | --- | --- |
| Actual deployed source | `107457d89399dcfc610ac635a4d3acf3ce4b9430` | 109 PASS | 144 PASS |
| PR15 undeployed diagnostic candidate | `539f33cd346e6eac8793599e38031986f3503afa` | 116 PASS | 144 PASS |

Both reruns used scripts/run_test_campaign.py, which launches deployment and research suites in separate interpreters. Dated campaign reports include exact Python source hashes. Repeated fixture passes are not additional independent market evidence. The original October11 research branch was already merged via PR1; its review was re-read for continuity, not treated as a current runtime snapshot. No applicable AGENTS instruction exists in this checkout or the previously inspected ancestors.

## Fresh platform/log evidence

- Main remains `96ad38db59e7ebf4c1bdad588b011918f4c9c76d`; PR15 is open/unmerged at the tested candidate above.
- Production remains SUCCESS deployment `16bfa522-3998-4507-a203-2d6c84a084d1` at `107457d...`. Platform reports one running replica, zero crashed replicas and no deployment failures, warnings or critical notifications in the queried 24-hour window. This is a status snapshot, not sustained uptime or collector completeness certification.
- Pending patch `f0e0cf8e-8fbf-49d0-8dc4-2ab0df144113` is still staged and was not accepted or modified.
- A bounded recent NEWS_HEALTH retrieval returned six records, from `2026-10-19T02:52:50.462Z` through `03:19:10.962Z`, all RESEARCH_ONLY, COMPLETE_DELAYED_WINDOW and execution_enabled=false. All reported zero newly accepted records. These are delayed-news health observations, not valid executable quotes, strategy fills or account returns.
- A separate service-log query from `2026-10-18T03:20:00Z` to `2026-10-19T03:20:00Z`, filter `Traceback OR ERROR OR VALIDATION_FAILED`, limit100, returned zero matches. This does not prove absence of all errors or resolve older review/bootstrap failures.

There has been no new regular US session since the already-reviewed Friday sample. No new stale/spread pattern can be inferred from weekend news polling. The previous October15 lab observation gap remains unresolved. No new private `/audit` reply, mounted action-review file, journal, ledger or copied recovery archive became available. Therefore current reconciliation, corporate-action block status, session validity and private performance cannot be newly certified. The retrospective October8–16 review remains dated; it was not extended for later sessions or wired into startup.

## Decision and next evidence

No speculative code fix, threshold tuning or duplicate strategy search was added. Existing risk pauses, action-review requirements, receipt-time news rules, frozen experiments, ordinary/doubled-cost alternatives and historical invalid days remain unchanged. Historical price inputs were not recovered or newly evaluated in this check.

Next evidence remains an authorized owner `/audit` diagnostic and read-only reconciliation against copied private state. Any repair must follow the actual fixed reason codes and independently reviewed date coverage, not assume the files match public repository defaults. No production writes, deployment, credential copying, paid services, live orders or public private-ledger publication occurred. Current private P/L and profitability remain unknown.
